Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues

Tissue Antigens
F XieX Zhang

Abstract

OX40, a membrane-bound molecule of the tumor-necrosis-factor-receptor superfamily, is a critical costimulatory receptor during the immune response. Here, we newly generated two specific mouse antihuman OX40 monoclonal antibodies (mAbs) (2G2 and 1F7), whose specificities are quite different from the available OX40 mAb (ACT35) by competition assay. It was also found that both mAbs could enhance the proliferation, activation and differentiation of T lymphocytes primed by anti-CD3 mAb. These results evidenced that both were functional antihuman OX40 mAbs. Furthermore, stained by 2G2 and 1F7, FCM and immunohistochemistry detected the constitutive expression of OX40 on tumor cell lines from epithelium, breast cancer and glioma tissues. Meanwhile, the non-tumor tissues (thyroid gland, stomach gland) were also found OX40 expression. These results suggested that OX40 is not only expressed in activated T cells, but also in some tumors as well as normal gland tissues. Such expression pattern indicated that OX40 may be a valuable surface antigen in unveiling its expression and function outside the immune system. Briefly, these novel antibodies may contribute to the evaluation of the mechanism of tumor metastasis and eventually shed light o...Continue Reading

References

Jan 1, 1980·Journal of Immunological Methods·S F de StGroth, D Scheidegger
Apr 1, 1995·European Journal of Immunology·M L BirkelandA N Barclay
Jul 3, 1998·British Journal of Rheumatology·D BrugnoniR Cattaneo
Oct 29, 1998·Biochemical and Biophysical Research Communications·H AkibaK Okumura
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A D WeinbergJ Shields
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·I GramagliaM Croft
Mar 7, 2001·Cellular and Molecular Life Sciences : CMLS·U Schönbeck, P Libby
Aug 2, 2001·Nature Medicine·P Bansal-PakalaM Croft
Aug 24, 2001·Breast Cancer Research and Treatment·A MorrisA D Weinberg
Dec 19, 2002·Cancer Gene Therapy·Alex W Tong, Marvin J Stone
Jun 3, 2004·Nature Reviews. Immunology·Kazuo SugamuraAndrew D Weinberg
Sep 17, 2005·Cancer Research·Che-Leung LawIqbal S Grewal

❮ Previous
Next ❯

Citations

May 8, 2019·Cancers·Sebastian ChrétienTheodoros Foukakis
Sep 10, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kui S VooYong J Liu
Oct 8, 2011·International Journal of Immunopathology and Pharmacology·Q ShiYu Hua Qiu
Jan 12, 2021·Journal for Immunotherapy of Cancer·Jordana GriffithsMark S Cragg
Jul 9, 2021·JCI Insight·Toshihito HiraiSanjiv S Gambhir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.